W, L., A, Z., MTS, Y., A, W., MS, V., A, T., . . . M, Y. (2023). Serologic reactivity of unidentified specificity in antenatal testing and hemolytic disease of the fetus and newborn: The BEST collaborative study. Transfusion, 63(4), 817. https://doi.org/10.1111/trf.17276
Chicago Style (17th ed.) CitationW, Lu, et al. "Serologic Reactivity of Unidentified Specificity in Antenatal Testing and Hemolytic Disease of the Fetus and Newborn: The BEST Collaborative Study." Transfusion 63, no. 4 (2023): 817. https://doi.org/10.1111/trf.17276.
MLA (9th ed.) CitationW, Lu, et al. "Serologic Reactivity of Unidentified Specificity in Antenatal Testing and Hemolytic Disease of the Fetus and Newborn: The BEST Collaborative Study." Transfusion, vol. 63, no. 4, 2023, p. 817, https://doi.org/10.1111/trf.17276.